October 22nd 2024
HPV vaccination in Brazil led to significant reductions in genital warts and cervical precancer hospitalizations, especially among those under 20 years of age.
Tackling Inequities in IBD: Inclusive Solutions for Elevated Patient Care
October 26, 2024
Register Now!
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Helping "vulnerable" children-and their parents-lead normal lives
June 1st 2006Vulnerable child syndrome distorts parents' perceptions of their child's health, disrupts the parent-child relationship, and can harm development and behavior in an otherwise healthy child. Here are steps you can take to recognize problems early and improve family interactions.
HPV vaccination may pose delivery concerns
April 29th 2006Pediatricians can expect problems meeting vaccination schedules forhuman papillomavirus (HPV) vaccine. Based on data from the 1996 to2002 Medical Expenditure Panel Survey, only 11% of adolescents haveprimary care visits on a schedule appropriate to HPV vaccination.
When a teen has a tot: A model of care for the adolescent parent and her child
April 1st 2006You can mitigate the health and educational risks faced by an adolescent parent and her child by providing a medical home for both. This "teen-tot" model of family-centered care provides a framework for success.
Answers to key questions about childhood leukemia--for the generalist
March 1st 2006What goes wrong with blood cells and genes of children who suffer this grim disease? And how has a high cure rate revealed late effects of treatment? Answers to these (and more) questions shape your ongoing basic care of patients at the onset of, during, and after their illness.
Progress in preventing cervical cancer and other HPV-related diseases, Part 1
March 1st 2006Expanding knowledge, new screening technologies, and effective vaccines have opened new horizons in, and put pediatricians at the forefront of, preventing cervical cancer and other diseases caused by human papillomavirus. Here's what we know now and what it means for your patients. First of two parts.
Trials show that two vaccines are effective against genital cancers and warts
January 13th 2006Two separate studies show that Merck & Co.'s and GlaxoSmithKline's human papillomavirus (HPV) vaccines appear highly effective in preventing cervical cancer, vulvar cancer, and genital warts.The recently completed trials involved Merck's Gardasil and GlaxoSmithKline's experimental vaccine. Earlier studies showed that Gardasil also protects against cervical intraepithelial neoplasia (CIN)-precancerous lesions that can develop into cervical cancer.
Success of NO treatment for term babies doesn't extend to preemies
August 5th 2005Contrary to earlier findings, inhaled nitric oxide (NO) therapy for lung immaturity in premature infants does not reduce an infant's risk of death or further lung problems, according to a study by the National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health that appeared in the July 7 issue of the New England Journal of Medicine. "Premature infants weighing less than 1,500 g should not receive inhaled NO therapy unless they are part of a research study," said NICHD Director Duane Alexander, MD.